Pubblicazioni presenti sul Catalogo Istituzionale

Elenco delle pubblicazioni

1: Russo D, Merolla F, Mascolo M, Ilardi G, Romano S, Varricchio S, Napolitano V,
Celetti A, Postiglione L, Di Lorenzo PP, Califano L, Dell'Aversana GO, Astarita
F, Romano MF, Staibano S. FKBP51 Immunohistochemical Expression: A New Prognostic
Biomarker for OSCC? Int J Mol Sci. 2017 Feb 18;18(2). pii: E443. doi:
10.3390/ijms18020443. PubMed PMID: 28218707.


2: Mazzella C, Costa C, Fabbrocini G, Marangi GF, Russo D, Merolla F, Scalvenzi
M. Nevoid hyperkeratosis of the nipple mimicking a pigmented basal cell
carcinoma. JAAD Case Rep. 2016 Dec 7;2(6):500-501. doi:
10.1016/j.jdcr.2016.09.007. PubMed PMID: 28004028; PubMed Central PMCID:
PMC5161776.


3: Malapelle U, Morra F, Ilardi G, Visconti R, Merolla F, Cerrato A, Napolitano
V, Monaco R, Guggino G, Monaco G, Staibano S, Troncone G, Celetti A. USP7
inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to
PARP-inhibitor drugs. Lung Cancer. 2016 Jun 17. pii: S0169-5002(16)30373-7. doi: 
10.1016/j.lungcan.2016.06.015. [Epub ahead of print] PubMed PMID: 27372520.


4: Pannone G, Bufo P, Pace M, Lepore S, Russo GM, Rubini C, Franco R, Aquino G,
Santoro A, Campisi G, Rodolico V, Bucci E, Ilardi G, Mascolo M, Merolla F, Lo
Muzio L, Natalicchio I, Colella G, Laurenzana I, Trino S, Leonardi R, Bucci P.
TLR4 down-regulation identifies high risk HPV infection and integration in head
and neck squamous cell carcinomas. Front Biosci (Elite Ed). 2016 Jan 1;8:15-28.
PubMed PMID: 26709642.


5: Merolla F, Mascolo M, Ilardi G, Siano M, Russo D, Graziano V, Celetti A,
Staibano S. Nucleotide Excision Repair and head and neck cancers. Front Biosci
(Landmark Ed). 2016 Jan 1;21:55-69. Review. PubMed PMID: 26709761.


6: Caroppo D, Russo D, Merolla F, Ilardi G, Del Basso de Caro M, Di Lorenzo P,
Varricchio S, Mascolo M, Staibano S. A rare case of coexistence of metastasis
from head and neck squamous cell carcinoma and tuberculosis within a neck lymph
node. Diagn Pathol. 2015 Oct 29;10:197. doi: 10.1186/s13000-015-0430-x. PubMed
PMID: 26510425; PubMed Central PMCID: PMC4625527.


7: Cozzolino I, Zeppa P, Zabatta A, Merolla F, Vetrani A, Sadile F. Benign
chondroblastoma on fine-needle aspiration smears: A seven-case experience and
review of the literature. Diagn Cytopathol. 2015 Sep;43(9):734-8. doi:
10.1002/dc.23286. Review. PubMed PMID: 25914148.


8: Napolitano S, Martini G, Rinaldi B, Martinelli E, Donniacuo M, Berrino L,
Vitagliano D, Morgillo F, Barra G, De Palma R, Merolla F, Ciardiello F, Troiani
T. Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal
Antibody Can Be Overcome by Combined Treatment of Regorafenib with Cetuximab.
Clin Cancer Res. 2015 Jul 1;21(13):2975-83. doi: 10.1158/1078-0432.CCR-15-0020.
PubMed PMID: 25838391.


9: Romano S, D'Angelillo A, Staibano S, Simeone E, D'Arrigo P, Ascierto PA,
Scalvenzi M, Mascolo M, Ilardi G, Merolla F, Jovarauskaite E, Romano MF.
Immunomodulatory pathways regulate expression of a spliced FKBP51 isoform in
lymphocytes of melanoma patients. Pigment Cell Melanoma Res. 2015
Jul;28(4):442-52. doi: 10.1111/pcmr.12378. PubMed PMID: 25895097.


10: Leone V, Langella C, Esposito F, Arra C, Palma G, Rea D, Paciello O, Merolla 
F, De Biase D, Papparella S, Celetti A, Fusco A. Ccdc6 knock-in mice develop
thyroid hyperplasia associated to an enhanced CREB1 activity. Oncotarget. 2015
Jun 20;6(17):15628-38. PubMed PMID: 25970781; PubMed Central PMCID: PMC4558175.


11: Morra F, Luise C, Merolla F, Poser I, Visconti R, Ilardi G, Paladino S,
Inuzuka H, Guggino G, Monaco R, Colecchia D, Monaco G, Cerrato A, Chiariello M,
Denning K, Claudio PP, Staibano S, Celetti A. FBXW7 and USP7 regulate CCDC6
turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC.
Oncotarget. 2015 May 20;6(14):12697-709. PubMed PMID: 25885523; PubMed Central
PMCID: PMC4494967.


12: Morra F, Luise C, Visconti R, Staibano S, Merolla F, Ilardi G, Guggino G,
Paladino S, Sarnataro D, Franco R, Monaco R, Zitomarino F, Pacelli R, Monaco G,
Rocco G, Cerrato A, Linardopoulos S, Muller MT, Celetti A. New therapeutic
perspectives in CCDC6 deficient lung cancer cells. Int J Cancer. 2015 May
1;136(9):2146-57. doi: 10.1002/ijc.29263. PubMed PMID: 25302833.


13: Bellelli R, Castellone MD, Guida T, Limongello R, Dathan NA, Merolla F,
Cirafici AM, Affuso A, Masai H, Costanzo V, Grieco D, Fusco A, Santoro M,
Carlomagno F. NCOA4 transcriptional coactivator inhibits activation of DNA
replication origins. Mol Cell. 2014 Jul 3;55(1):123-37. doi:
10.1016/j.molcel.2014.04.031. PubMed PMID: 24910095.


14: Natella V, Merolla F, Giampaolino P, Bifulco G, Mainenti PP, Insabato L. A
huge malignant perivascular epithelioid cell tumor (PEComa) of the uterine cervix
and vagina. Pathol Res Pract. 2014 Mar;210(3):186-8. doi:
10.1016/j.prp.2013.10.003. PubMed PMID: 24331571.


15: Ilardi G, Zambrano N, Merolla F, Siano M, Varricchio S, Vecchione M, De Rosa 
G, Mascolo M, Staibano S. Histopathological determinants of tumor resistance: a
special look to the immunohistochemical expression of carbonic anhydrase IX in
human cancers. Curr Med Chem. 2014;21(14):1569-82. Review. PubMed PMID: 23992304;
PubMed Central PMCID: PMC3979091.


16: Martinelli E, Troiani T, D'Aiuto E, Morgillo F, Vitagliano D, Capasso A,
Costantino S, Ciuffreda LP, Merolla F, Vecchione L, De Vriendt V, Tejpar S, Nappi
A, Sforza V, Martini G, Berrino L, De Palma R, Ciardiello F. Antitumor activity
of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR
inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human
lung and colorectal cancer cells. Int J Cancer. 2013 Nov;133(9):2089-101. doi:
10.1002/ijc.28236. PubMed PMID: 23629727.


17: Staibano S, Ilardi G, Leone V, Luise C, Merolla F, Esposito F, Morra F, Siano
M, Franco R, Fusco A, Chieffi P, Celetti A. Critical role of CCDC6 in the
neoplastic growth of testicular germ cell tumors. BMC Cancer. 2013 Sep 24;13:433.
doi: 10.1186/1471-2407-13-433. PubMed PMID: 24059746; PubMed Central PMCID:
PMC3849521.


18: Mascolo M, Ilardi G, Romano MF, Celetti A, Siano M, Romano S, Luise C,
Merolla F, Rocco A, Vecchione ML, De Rosa G, Staibano S. Overexpression of
chromatin assembly factor-1 p60, poly(ADP-ribose) polymerase 1 and nestin
predicts metastasizing behaviour of oral cancer. Histopathology. 2012
Dec;61(6):1089-105. doi: 10.1111/j.1365-2559.2012.04313.x. PubMed PMID: 22882088;
PubMed Central PMCID: PMC3546388.


19: Mascolo M, Ilardi G, Merolla F, Russo D, Vecchione ML, de Rosa G, Staibano S.
Tissue microarray-based evaluation of Chromatin Assembly Factor-1 (CAF-1)/p60 as 
tumour prognostic marker. Int J Mol Sci. 2012;13(9):11044-62. doi:
10.3390/ijms130911044. PubMed PMID: 23109837; PubMed Central PMCID: PMC3472729.


20: Mascolo M, Siano M, Ilardi G, Russo D, Merolla F, De Rosa G, Staibano S.
Epigenetic disregulation in oral cancer. Int J Mol Sci. 2012;13(2):2331-53. doi: 
10.3390/ijms13022331. Review. PubMed PMID: 22408457; PubMed Central PMCID:
PMC3292026.


21: Luise C, Merolla F, Leone V, Paladino S, Sarnataro D, Fusco A, Celetti A.
Identification of sumoylation sites in CCDC6, the first identified RET partner
gene in papillary thyroid carcinoma, uncovers a mode of regulating CCDC6 function
on CREB1 transcriptional activity. PLoS One. 2012;7(11):e49298. doi:
10.1371/journal.pone.0049298. PubMed PMID: 23145146; PubMed Central PMCID:
PMC3492267.


22: Merolla F, Luise C, Muller MT, Pacelli R, Fusco A, Celetti A. Loss of CCDC6, 
the first identified RET partner gene, affects pH2AX S139 levels and accelerates 
mitotic entry upon DNA damage. PLoS One. 2012;7(5):e36177. doi:
10.1371/journal.pone.0036177. PubMed PMID: 22655027; PubMed Central PMCID:
PMC3360053.


23: Leone V, Mansueto G, Pierantoni GM, Tornincasa M, Merolla F, Cerrato A,
Santoro M, Grieco M, Scaloni A, Celetti A, Fusco A. CCDC6 represses CREB1
activity by recruiting histone deacetylase 1 and protein phosphatase 1. Oncogene.
2010 Jul 29;29(30):4341-51. doi: 10.1038/onc.2010.179. PubMed PMID: 20498639.


24: Staibano S, Merolla F, Testa D, Iovine R, Mascolo M, Guarino V, Castellone
MD, Di Benedetto M, Galli V, Motta S, Melillo RM, De Rosa G, Santoro M, Celetti
A. OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical
outcome. Br J Cancer. 2007 Dec 3;97(11):1545-51. PubMed PMID: 17987038; PubMed
Central PMCID: PMC2360266.


25: Merolla F, Pentimalli F, Pacelli R, Vecchio G, Fusco A, Grieco M, Celetti A. 
Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage.
Oncogene. 2007 Sep 13;26(42):6167-75. PubMed PMID: 17420723.


26: Celetti A, Testa D, Staibano S, Merolla F, Guarino V, Castellone MD, Iovine
R, Mansueto G, Somma P, De Rosa G, Galli V, Melillo RM, Santoro M. Overexpression
of the cytokine osteopontin identifies aggressive laryngeal squamous cell
carcinomas and enhances carcinoma cell proliferation and invasiveness. Clin
Cancer Res. 2005 Nov 15;11(22):8019-27. PubMed PMID: 16299231.


27: Motti ML, Califano D, Baldassarre G, Celetti A, Merolla F, Forzati F,
Napolitano M, Tavernise B, Fusco A, Viglietto G. Reduced E-cadherin expression
contributes to the loss of p27kip1-mediated mechanism of contact inhibition in
thyroid anaplastic carcinomas. Carcinogenesis. 2005 Jun;26(6):1021-34. PubMed
PMID: 15718252.


28: Celetti A, Cerrato A, Merolla F, Vitagliano D, Vecchio G, Grieco M.
H4(D10S170), a gene frequently rearranged with RET in papillary thyroid
carcinomas: functional characterization. Oncogene. 2004 Jan 8;23(1):109-21.
PubMed PMID: 14712216.